BioTech

#TradeTalks: The Saliva-Based CRL Rapid Response Test is Focused on Getting Businesses Back to Work

Published
    Sep 3, 2020

    The saliva-based CRL Rapid Response Test is focused on getting businesses and schools back to work. Clinical Reference Laboratories CEO Robert Thompson joins Jill Malandrino on Nasdaq #TradeTalks to discuss.

    Nasdaq Watch

    See what's playing at Nasdaq

    Watch Now